- Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients
-
Lee HM, Jang IA, Lee D, Kang EJ, Choi BS, Park CW, Choi YJ, Yang CW, Kim YS, Chung BH
- KMID: 2381591
- Korean J Intern Med.
- 2015 Nov;30(6):865-872.
- doi: 10.3904/kjim.2015.30.6.865
BACKGROUND/AIMS: BK virus-associated nephropathy (BKVAN) is an important cause of allograft dysfunction in kidney transplant recipients. It has an unfavorable clinical course, and no definite treatment guidelines have yet been... -
- CITED
-
- Close
- SHARE
-
- Close
- Quantitation of BK Virus DNA for Diagnosis of BK Virus-Associated Nephropathy in Renal Transplant Recipients
-
Sung H, Choi BH, Pyo YJ, Kim MN, Han DJ
- KMID: 1783066
- J Korean Med Sci.
- 2008 Oct;23(5):814-818.
- doi: 10.3346/jkms.2008.23.5.814
Quantitative measurement of BK virus DNA (Q-BKDNA) has been used for the early diagnosis and monitoring of BK virus-associated nephropathy (BKVAN). This study was designed to determine the BKDNA cutoff... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation
-
Lee SS, Ahn JS, Jung SH, Ahn SY, Kim JY, Jang HC, Kang SJ, Jang MO, Yang DH, Kim YK, Lee JJ, Kim HJ
- KMID: 2160686
- Korean J Intern Med.
- 2015 Mar;30(2):212-218.
- doi: 10.3904/kjim.2015.30.2.212
BACKGROUND/AIMS: BK virus (BKV) has been associated with late-onset hemorrhagic cystitis (HC) in recipients of hematopoietic stem cell transplantation (HSCT). Cidofovir has been used at higher doses (3 to 5... -
- CITED
-
- Close
- SHARE
-
- Close
